8-K - IGC Pharma, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Financing

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement Extension of Master Loan and Security Agreement On July 29, 2024, IGC Pharma, Inc. (“IGC” or the “Company”) entered i

Material Agreement

$120.0K$84.0K

Source Document

2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 is inc

Financing

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No . Description 10.1* Extension of Master Loan Agreement between IGC Pharma, Inc. and O-Bank, CO., LTD.

Exhibits Only

Exhibits (2)

10.1

EXHIBIT 10.1

8-K

FORM 8-K